Nevro (NVRO) Stock Forecast, Price Target & Predictions
NVRO Stock Forecast
Nevro stock forecast is as follows: an average price target of $32.99 (represents a 469.78% upside from NVRO’s last price of $5.79) and a rating consensus of 'Hold', based on 18 wall street analysts offering a 1-year stock forecast.
NVRO Price Target
The average price target for Nevro (NVRO) is $32.99 based on 1-year price targets from 18 Wall Street analysts in the past 3 months, with a price target range of $125.00 to $5.50. This represents a potential 469.78% upside from NVRO's last price of $5.79.
NVRO Analyst Ratings
According to 18 Wall Street analysts, Nevro's rating consensus is 'Hold'. The analyst rating breakdown for NVRO stock is 0 'Strong Buy' (0.00%), 7 'Buy' (38.89%), 9 'Hold' (50.00%), 2 'Sell' (11.11%), and 0 'Strong Sell' (0.00%).
Nevro Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 08, 2024 | Joanna Wuensch | Citigroup | $6.89 | $5.67 | 21.52% | 19.00% |
| Aug 08, 2024 | Richard Newitter | Truist Financial | $5.50 | $5.08 | 8.27% | -5.01% |
| Aug 07, 2024 | David Rescott | Robert W. Baird | $8.00 | $5.00 | 60.00% | 38.17% |
| Aug 07, 2024 | Matthew Taylor | Jefferies | $7.00 | $4.83 | 44.93% | 20.90% |
| Aug 07, 2024 | Adam Maeder | Piper Sandler | $7.00 | $8.69 | -19.45% | 20.90% |
| Aug 07, 2024 | Nathan Treybeck | Wells Fargo | $5.50 | $8.69 | -36.71% | -5.01% |
| Apr 11, 2024 | Anthony Petrone | Mizuho Securities | $16.00 | $13.28 | 20.48% | 176.34% |
| Apr 08, 2024 | Nathan Treybeck | Wells Fargo | $14.00 | $13.29 | 5.34% | 141.80% |
| Jun 06, 2023 | Suraj Kalia | Oppenheimer | $40.00 | $23.71 | 68.72% | 590.85% |
| Feb 06, 2023 | - | Canaccord Genuity | $72.00 | $39.15 | 83.91% | 1143.52% |
The latest Nevro stock forecast, released on Aug 08, 2024 by Joanna Wuensch from Citigroup, set a price target of $6.89, which represents a 21.52% increase from the stock price at the time of the forecast ($5.67), and a 19.00% increase from NVRO last price ($5.79).
Nevro Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 6 | 8 |
| Avg Price Target | - | $6.65 | $8.74 |
| Last Closing Price | $5.79 | $5.79 | $5.79 |
| Upside/Downside | -100.00% | 14.85% | 50.95% |
In the current month, the average price target of Nevro stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Nevro's last price of $5.79. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 08, 2024 | Citigroup | Sell | Neutral | Upgrade |
| Aug 08, 2024 | Wolfe Research | - | Peer Perform | Upgrade |
| Aug 07, 2024 | Jefferies | Underperform | Underperform | Hold |
| Aug 07, 2024 | Piper Sandler | Underweight | Underweight | Hold |
| Aug 07, 2024 | Wells Fargo | Equal-Weight | Underweight | Downgrade |
| Aug 07, 2024 | JMP Securities | Perform | Market Perform | Downgrade |
| Aug 07, 2024 | JMP Securities | - | Perform | Downgrade |
| Jul 10, 2024 | Citigroup | Sell | Sell | Hold |
| May 22, 2024 | Citigroup | Neutral | Sell | Downgrade |
| Apr 03, 2024 | Citigroup | Neutral | Neutral | Hold |
Nevro's last stock rating was published by Citigroup on Aug 08, 2024. The company Upgrade its NVRO rating from "Sell" to "Neutral".
Nevro Financial Forecast
Nevro Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $103.86M | $108.81M | $96.33M | $113.84M | $100.47M | - | $87.84M | $102.76M | $93.20M | $102.33M | $88.61M | $109.73M | $108.46M | $56.39M | $87.47M | $114.37M | $100.16M |
| Avg Forecast | $137.69M | $119.66M | $123.90M | $109.49M | $112.54M | $99.74M | $105.56M | $100.15M | $103.35M | $93.09M | $107.11M | $97.90M | $112.26M | $95.87M | $108.19M | $95.08M | $113.42M | $99.22M | $104.34M | $86.19M | $100.26M | $91.59M | $102.32M | $85.26M | $107.92M | $104.00M | $37.86M | $88.06M | $111.80M | $92.27M |
| High Forecast | $139.08M | $120.87M | $125.15M | $110.59M | $113.68M | $100.74M | $106.62M | $101.16M | $104.40M | $93.97M | $108.20M | $98.88M | $112.33M | $104.57M | $109.28M | $96.04M | $114.57M | $100.22M | $104.34M | $87.50M | $101.79M | $92.99M | $103.89M | $86.56M | $109.57M | $105.59M | $38.43M | $89.40M | $113.51M | $93.68M |
| Low Forecast | $136.09M | $118.27M | $122.46M | $108.22M | $111.23M | $98.58M | $104.33M | $98.99M | $102.16M | $92.00M | $105.87M | $96.76M | $112.05M | $94.58M | $106.93M | $93.98M | $112.11M | $98.07M | $104.34M | $84.36M | $98.14M | $89.65M | $100.16M | $83.46M | $105.64M | $101.80M | $37.05M | $86.19M | $109.44M | $90.32M |
| # Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 2 | 4 | 15 | 9 | 9 | 13 | 13 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 8 | 7 | 10 | 9 | 6 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | 1.01% | 1.01% | 1.00% | 1.01% | - | 1.02% | 1.02% | 1.02% | 1.00% | 1.04% | 1.02% | 1.04% | 1.49% | 0.99% | 1.02% | 1.09% |
Nevro's average Quarter revenue forecast for Dec 23 based on 4 analysts is $112.26M, with a low forecast of $112.05M, and a high forecast of $112.33M. NVRO's average Quarter revenue forecast represents a 8.09% increase compared to the company's last Quarter revenue of $103.86M (Sep 23).
Nevro EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 2 | 4 | 15 | 9 | 9 | 13 | 13 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 8 | 7 | 10 | 9 | 6 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-25.56M | $-25.64M | $-36.32M | $-19.36M | $-18.75M | - | $-30.04M | $-24.00M | $-44.13M | $-13.59M | $-20.68M | $1.69M | $-1.39M | $-32.87M | $-19.63M | $-8.41M | $-12.76M |
| Avg Forecast | $-36.14M | $-31.40M | $-32.52M | $-28.73M | $-29.54M | $-26.17M | $-27.70M | $-26.28M | $-27.12M | $-24.43M | $-28.11M | $-40.31M | $-29.46M | $-25.16M | $-28.39M | $-36.65M | $-29.77M | $-46.24M | $-27.38M | $-33.31M | $-24.00M | $-36.55M | $-15.31M | $-20.44M | $2.30M | $-1.88M | $-41.19M | $-23.80M | $-10.85M | $-16.81M |
| High Forecast | $-35.72M | $-31.04M | $-32.14M | $-28.40M | $-29.19M | $-25.87M | $-27.38M | $-25.98M | $-26.81M | $-24.14M | $-27.78M | $-32.25M | $-29.41M | $-24.82M | $-28.06M | $-29.32M | $-29.42M | $-36.99M | $-27.38M | $-26.65M | $-19.20M | $-29.24M | $-12.25M | $-16.35M | $2.76M | $-1.50M | $-32.95M | $-19.04M | $-8.68M | $-13.45M |
| Low Forecast | $-36.50M | $-31.72M | $-32.85M | $-29.02M | $-29.83M | $-26.44M | $-27.98M | $-26.55M | $-27.40M | $-24.66M | $-28.40M | $-48.37M | $-29.48M | $-27.44M | $-28.68M | $-43.98M | $-30.07M | $-55.48M | $-27.38M | $-39.98M | $-28.80M | $-43.86M | $-18.37M | $-24.53M | $1.84M | $-2.26M | $-49.43M | $-28.56M | $-13.03M | $-20.17M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.90% | 0.99% | 0.65% | 0.41% | - | 0.90% | 1.00% | 1.21% | 0.89% | 1.01% | 0.73% | 0.74% | 0.80% | 0.83% | 0.78% | 0.76% |
7 analysts predict NVRO's average Quarter EBITDA for Mar 21 to be $-20.44M, with a high of $-16.35M and a low of $-24.53M. This is -1311.54% lower than Nevro's previous annual EBITDA (Dec 20) of $1.69M.
Nevro Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 2 | 4 | 15 | 9 | 9 | 13 | 13 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 8 | 7 | 10 | 9 | 6 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-23.48M | $-24.72M | $-35.03M | $-19.19M | $81.51M | - | $-34.33M | $-30.13M | $-50.08M | $-21.59M | $-29.56M | $-7.13M | $-9.98M | $-41.06M | $-24.89M | $-13.74M | $-17.85M |
| Avg Forecast | $-9.97M | $-14.41M | $-12.19M | $-20.32M | $-19.64M | $-26.11M | $-21.85M | $-30.38M | $-25.53M | $-30.41M | $-25.76M | $-46.06M | $-18.07M | $-28.40M | $-25.48M | $-41.88M | $-18.01M | $-52.47M | $-29.47M | $-38.07M | $-30.13M | $-41.48M | $-24.33M | $-29.21M | $-9.72M | $-13.56M | $-51.46M | $-30.17M | $-17.73M | $-23.52M |
| High Forecast | $-9.82M | $-14.19M | $-12.01M | $-20.01M | $-19.35M | $-25.72M | $-21.52M | $-29.93M | $-25.15M | $-24.85M | $-25.37M | $-36.85M | $-15.18M | $-16.23M | $-25.10M | $-33.50M | $-17.74M | $-41.97M | $-29.47M | $-30.46M | $-24.11M | $-33.18M | $-19.46M | $-23.37M | $-7.78M | $-10.84M | $-41.16M | $-24.13M | $-14.19M | $-18.81M |
| Low Forecast | $-10.10M | $-14.59M | $-12.35M | $-20.58M | $-19.90M | $-26.46M | $-22.13M | $-30.78M | $-25.87M | $-36.35M | $-26.09M | $-55.28M | $-20.96M | $-33.56M | $-25.82M | $-50.25M | $-18.25M | $-62.96M | $-29.47M | $-45.68M | $-36.16M | $-49.77M | $-29.19M | $-35.05M | $-11.67M | $-16.27M | $-61.75M | $-36.20M | $-21.28M | $-28.22M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.83% | 0.97% | 0.84% | 1.07% | -1.55% | - | 0.90% | 1.00% | 1.21% | 0.89% | 1.01% | 0.73% | 0.74% | 0.80% | 0.83% | 0.78% | 0.76% |
Nevro's average Quarter net income forecast for Dec 22 is $-18.01M, with a range of $-18.25M to $-17.74M. NVRO's average Quarter net income forecast represents a -122.10% decrease compared to the company's last Quarter net income of $81.51M (Sep 22).
Nevro SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 2 | 4 | 15 | 9 | 9 | 13 | 13 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 8 | 7 | 10 | 9 | 6 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $81.15M | $86.76M | $86.19M | $80.65M | $78.19M | - | $79.33M | $82.64M | $79.52M | $73.88M | $73.27M | $67.07M | $68.51M | $60.17M | $71.40M | $76.01M | $72.91M |
| Avg Forecast | $106.69M | $92.72M | $96.01M | $84.84M | $87.20M | $77.28M | $81.79M | $77.60M | $80.09M | $72.13M | $83.00M | $75.86M | $86.99M | $74.29M | $83.83M | $73.67M | $87.89M | $83.32M | $80.85M | $66.78M | $82.64M | $65.87M | $83.25M | $72.40M | $91.46M | $93.01M | $29.33M | $86.55M | $98.07M | $71.50M |
| High Forecast | $107.77M | $93.66M | $96.98M | $85.69M | $88.09M | $78.06M | $82.62M | $78.39M | $80.90M | $72.82M | $83.84M | $76.62M | $87.04M | $81.03M | $84.68M | $74.42M | $88.78M | $99.98M | $80.85M | $67.80M | $99.17M | $79.04M | $99.89M | $86.88M | $109.76M | $111.62M | $29.78M | $103.86M | $117.69M | $72.59M |
| Low Forecast | $105.45M | $91.65M | $94.89M | $83.85M | $86.19M | $76.39M | $80.84M | $76.70M | $79.16M | $71.29M | $82.04M | $74.98M | $86.83M | $73.28M | $82.86M | $72.82M | $86.87M | $66.66M | $80.85M | $65.37M | $66.11M | $52.69M | $66.60M | $57.92M | $73.17M | $74.41M | $28.71M | $69.24M | $78.46M | $69.99M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.09% | 1.03% | 1.17% | 0.92% | 0.94% | - | 1.19% | 1.00% | 1.21% | 0.89% | 1.01% | 0.73% | 0.74% | 2.05% | 0.83% | 0.78% | 1.02% |
Nevro's average Quarter SG&A projection for Dec 23 is $86.99M, based on 4 Wall Street analysts, with a range of $86.83M to $87.04M. The forecast indicates a 7.20% rise compared to NVRO last annual SG&A of $81.15M (Sep 23).
Nevro EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 2 | 4 | 15 | 9 | 9 | 13 | 13 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 8 | 7 | 10 | 9 | 6 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.65 | $-0.69 | $-0.98 | $-0.54 | $2.30 | - | $-0.98 | $-0.86 | $-1.44 | $-0.62 | $-0.85 | $-0.21 | $-0.29 | $-1.21 | $-0.78 | $-0.44 | $-0.58 |
| Avg Forecast | $-0.27 | $-0.39 | $-0.33 | $-0.55 | $-0.53 | $-0.71 | $-0.59 | $-0.82 | $-0.69 | $-0.82 | $-0.70 | $-1.05 | $-0.49 | $-0.77 | $-0.69 | $-1.05 | $-0.49 | $-0.22 | $-0.81 | $-1.10 | $-0.86 | $-0.87 | $-0.73 | $-0.85 | $-0.33 | $-0.59 | $-1.63 | $-0.99 | $-0.63 | $-0.85 |
| High Forecast | $-0.27 | $-0.38 | $-0.33 | $-0.54 | $-0.52 | $-0.70 | $-0.58 | $-0.81 | $-0.68 | $-0.67 | $-0.69 | $-1.04 | $-0.41 | $-0.44 | $-0.68 | $-1.03 | $-0.48 | $-0.22 | $-0.81 | $-1.07 | $-0.83 | $-0.85 | $-0.71 | $-0.82 | $-0.32 | $-0.57 | $-1.58 | $-0.96 | $-0.62 | $-0.83 |
| Low Forecast | $-0.27 | $-0.40 | $-0.33 | $-0.56 | $-0.54 | $-0.72 | $-0.60 | $-0.83 | $-0.70 | $-0.98 | $-0.71 | $-1.07 | $-0.57 | $-0.91 | $-0.70 | $-1.06 | $-0.49 | $-0.23 | $-0.81 | $-1.12 | $-0.87 | $-0.89 | $-0.75 | $-0.86 | $-0.34 | $-0.60 | $-1.66 | $-1.01 | $-0.65 | $-0.87 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.85% | 1.00% | 0.93% | 1.11% | -10.25% | - | 0.89% | 1.00% | 1.65% | 0.85% | 1.00% | 0.63% | 0.49% | 0.74% | 0.79% | 0.70% | 0.68% |
According to 13 Wall Street analysts, Nevro's projected average Quarter EPS for Dec 22 is $-0.49, with a low estimate of $-0.49 and a high estimate of $-0.48. This represents a -121.20% decrease compared to NVRO previous annual EPS of $2.30 (Sep 22).
Nevro Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| NVRO | Nevro | $5.79 | $32.99 | 469.78% | Hold |
| CVRX | CVRx | $7.85 | $15.83 | 101.66% | Buy |
| OFIX | Orthofix Medical | $16.76 | $31.00 | 84.96% | - |
| NPCE | NeuroPace | $7.43 | $12.88 | 73.35% | Buy |
| FNA | Paragon 28 | $7.39 | $11.50 | 55.62% | Buy |
| SGHT | Sight Sciences | $6.95 | $10.33 | 48.63% | Hold |
| LUNG | Pulmonx | $8.31 | $12.25 | 47.41% | Buy |
| LIVN | LivaNova | $48.53 | $71.25 | 46.82% | Buy |
| CNMD | CONMED | $75.40 | $101.00 | 33.95% | Buy |
| KIDS | OrthoPediatrics | $32.28 | $40.80 | 26.39% | Buy |
| RXST | RxSight | $54.96 | $68.60 | 24.82% | Buy |
| IRMD | IRadimed | $48.47 | $60.00 | 23.79% | Buy |
| ITGR | Integer | $126.78 | $131.00 | 3.33% | Buy |
| SRDX | Surmodics | $39.36 | $39.50 | 0.36% | Buy |
| GKOS | Glaukos | $126.28 | $101.56 | -19.58% | Buy |
NVRO Forecast FAQ
Is Nevro a good buy?
No, according to 18 Wall Street analysts, Nevro (NVRO) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 38.89% of NVRO's total ratings.
What is NVRO's price target?
Nevro (NVRO) average price target is $32.99 with a range of $5.5 to $125, implying a 469.78% from its last price of $5.79. The data is based on 18 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Nevro stock go up soon?
According to Wall Street analysts' prediction for NVRO stock, the company can go up by 469.78% (from the last price of $5.79 to the average price target of $32.99), up by 2058.89% based on the highest stock price target, and down by -5.01% based on the lowest stock price target.
Can Nevro stock reach $9?
NVRO's average twelve months analyst stock price target of $32.99 supports the claim that Nevro can reach $9 in the near future.
What are Nevro's analysts' financial forecasts?
Nevro's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $417.98M (high $422.2M, low $413.13M), average EBITDA is $-110M (high $-108M, low $-111M), average net income is $-97.985M (high $-96.506M, low $-99.271M), average SG&A $323.88M (high $327.15M, low $320.12M), and average EPS is $-2.653 (high $-2.613, low $-2.688). NVRO's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $490.74M (high $495.7M, low $485.04M), average EBITDA is $-129M (high $-127M, low $-130M), average net income is $-56.883M (high $-56.025M, low $-57.63M), average SG&A $380.26M (high $384.1M, low $375.85M), and average EPS is $-1.54 (high $-1.517, low $-1.56).
Did the NVRO's actual financial results beat the analysts' financial forecasts?
Based on Nevro's last annual report (Dec 2022), the company's revenue was $406.36M, beating the average analysts forecast of $403.17M by 0.79%. Apple's EBITDA was $-204M, beating the average prediction of $-137M by 49.11%. The company's net income was $3M, missing the average estimation of $-138M by -102.17%. Apple's SG&A was $322.14M, beating the average forecast of $318.84M by 1.03%. Lastly, the company's EPS was $0.08, missing the average prediction of $-2.621 by -103.05%. In terms of the last quarterly report (Sep 2023), Nevro's revenue was $103.86M, beating the average analysts' forecast of $95.87M by 8.34%. The company's EBITDA was $-25.559M, beating the average prediction of $-25.16M by 1.59%. Nevro's net income was $-23.479M, missing the average estimation of $-28.4M by -17.33%. The company's SG&A was $81.15M, beating the average forecast of $74.29M by 9.24%. Lastly, the company's EPS was $-0.65, missing the average prediction of $-0.769 by -15.46%